Cord Blood America Names Business Development Director

LAS VEGAS, May 19 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board:CBAI.ob - News), the umbilical cord blood stem cell preservation company (www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that Lea Ann Stiller, whose daughter's life was saved with the first collection of umbilical cord blood stem cells for a bone marrow transplant, has been named Director of Business Development for the Company.

Cord Blood America CEO Discusses Company Strategy in Interview

LAS VEGAS, May 6 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company, is focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally. Matthew Schissler, Cord Blood America's Co-founder and CEO was interviewed this week by Tom Allinder of InBoundMarketingPR. During the interview, Mr. Schissler discusses Cord Blood America's goal of becoming the world's number one stem cell storage company.

Cord Blood America's CEO Matthew Schissler, in Analyst Interview, Discusses Significantly Increasing Revenues

LAS VEGAS, April 21 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (www.cordblood-america.com), is focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally. Its CEO and co-founder, Matthew Schissler, in an interview with analyst Francis Gaskins, said a focus this year is top-line revenue growth.